Helix BioMedix, Inc. (HXBM)
USD 7.18
(0.0%)
USD 7.18
(0.0%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 987.98 Thousand USD | -43.19% |
| 2022 | 1.73 Million USD | 0.0% |
| 2011 | 1.04 Million USD | 119.7% |
| 2010 | 477.41 Thousand USD | 644.19% |
| 2009 | 64.15 Thousand USD | -63.08% |
| 2008 | 173.74 Thousand USD | 14.89% |
| 2007 | 151.22 Thousand USD | 155.43% |
| 2006 | -272.8 Thousand USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 FY | 987.98 Thousand USD | -43.19% |
| 2022 FY | 1.73 Million USD | 0.0% |
| 2011 FY | 1.04 Million USD | 119.7% |
| 2010 FY | 477.41 Thousand USD | 644.19% |
| 2009 FY | 64.15 Thousand USD | -63.08% |
| 2008 FY | 173.74 Thousand USD | 14.89% |
| 2007 FY | 151.22 Thousand USD | 155.43% |
| 2006 FY | -272.8 Thousand USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Burzynski Research Institute, Inc. | - USD | -Infinity% |
| Arch Therapeutics, Inc. | -2439.00 USD | 40607.626% |
| Evofem Biosciences, Inc. | 11.7 Million USD | 91.56% |
| Nascent Biotech, Inc. | -319.5 Thousand USD | 409.22% |
| Rebus Holdings, Inc. | - USD | -Infinity% |
| Santhera Pharmaceuticals Holding AG | 119.1 Million USD | 99.171% |
| Qrons Inc. | - USD | -Infinity% |
| Adynxx, Inc. | - USD | -Infinity% |
| Neon Bloom, Inc. | - USD | -Infinity% |
| Northwest Biotherapeutics, Inc. | -25.79 Million USD | 103.83% |
| ProtoKinetix, Incorporated | -48.25 Thousand USD | 2147.247% |
| Skye Bioscience, Inc. | -124.25 Thousand USD | 895.149% |
| Eiger BioPharmaceuticals, Inc. | 14.99 Million USD | 93.413% |
| Nanobac Pharmaceuticals, Incorporated | 3102.00 USD | -31749.807% |
| Institute of Biomedical Research Corp. | - USD | -Infinity% |
| SQZ Biotechnologies Company | 9.79 Million USD | 89.912% |
| Intellipharmaceutics International Inc. | 65.72 Thousand USD | -1403.136% |
| Propanc Biopharma, Inc. | -34.15 Thousand USD | 2993.063% |
| Mesoblast Limited | -35.16 Million USD | 102.809% |
| Marizyme, Inc. | 457.7 Thousand USD | -115.857% |
| Genus plc | 178.7 Million USD | 99.447% |
| VioQuest Pharmaceuticals, Inc. | - USD | -Infinity% |
| Pharming Group N.V. | 220.1 Million USD | 99.551% |
| Therapeutic Solutions International, Inc. | 62.22 Thousand USD | -1487.73% |
| CNBX Pharmaceuticals Inc. | 410.16 Thousand USD | -140.874% |
| Nymox Pharmaceutical Corporation | -11 Thousand USD | 9081.645% |
| ContraFect Corporation | -154 Thousand USD | 741.546% |
| PsyBio Therapeutics Corp. | -50 Thousand USD | 2075.962% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | 76.76 Thousand USD | -1187.087% |
| IMV Inc. | -962.29 Thousand USD | 202.669% |
| AXIM Biotechnologies, Inc. | -387.5 Thousand USD | 354.962% |
| MultiCell Technologies, Inc. | 49.32 USD | -2003105.596% |
| ONE Bio Corp. | 20.12 Million USD | 95.091% |
| Accustem Sciences Inc. | - USD | -Infinity% |
| RVL Pharmaceuticals plc | 40.26 Million USD | 97.546% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| EV Biologics, Inc. | 48.9 Thousand USD | -1920.411% |
| Q BioMed Inc. | -8988.00 USD | 11092.223% |
| Emmaus Life Sciences, Inc. | 28.25 Million USD | 96.503% |
| Mosaic ImmunoEngineering Inc. | - USD | -Infinity% |
| Biomind Labs Inc. | -15.42 Thousand USD | 6505.478% |
| American Oriental Bioengineering, Inc. | 44.35 Million USD | 97.773% |
| Provectus Biopharmaceuticals, Inc. | -1.14 Million USD | 186.546% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| Oncotelic Therapeutics, Inc. | 70 Thousand USD | -1311.401% |
| GlobeStar Therapeutics Corporation | - USD | -Infinity% |
| THC Farmaceuticals, Inc. | -4952.00 USD | 20051.151% |
| Acro Biomedical Co., Ltd. | 140.5 Thousand USD | -603.189% |
| Curative Biotechnology, Inc. | -97.51 Thousand USD | 1113.158% |
| GB Sciences, Inc. | -624.00 USD | 158430.288% |
| Alpha Cognition Inc. | -86.02 Thousand USD | 1248.441% |
| HST Global, Inc. | - USD | -Infinity% |
| CSL Limited | 7.56 Billion USD | 99.987% |
| Wesana Health Holdings Inc. | - USD | -Infinity% |
| Halberd Corporation | -208.00 USD | 475090.865% |
| Enzolytics Inc. | 30.7 Thousand USD | -3117.341% |
| Agentix Corp. | - USD | -Infinity% |
| Resverlogix Corp. | - USD | -Infinity% |
| Nuo Therapeutics, Inc. | 482.43 Thousand USD | -104.791% |
| MetaStat, Inc. | - USD | -Infinity% |
| argenx SE | 1.1 Billion USD | 99.911% |
| Enzon Pharmaceuticals, Inc. | - USD | -Infinity% |
| Endonovo Therapeutics, Inc. | -514.51 Thousand USD | 292.024% |
| RespireRx Pharmaceuticals Inc. | - USD | -Infinity% |
| GeneThera, Inc. | - USD | -Infinity% |
| Inhibitor Therapeutics, Inc. | - USD | -Infinity% |
| AVAX Technologies, Inc. | 617.38 Thousand USD | -60.027% |
| Zenith Capital Corp. | - USD | -Infinity% |
| Genscript Biotech Corporation | 409.55 Million USD | 99.759% |
| Ember Therapeutics, Inc. | - USD | -Infinity% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sigyn Therapeutics, Inc. | -8856.00 USD | 11256.064% |
| WPD Pharmaceuticals Inc. | - USD | -Infinity% |
| Cotinga Pharmaceuticals Inc. | -83.84 Thousand USD | 1278.286% |
| Kadimastem Ltd | -630.13 Thousand USD | 256.788% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| Capstone Therapeutics Corp. | 9.61 Million USD | 89.72% |
| BioStem Technologies, Inc. | 15.42 Million USD | 93.595% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Reve Technologies, Inc. | - USD | -Infinity% |
| LadRx Corporation | -11.83 Thousand USD | 8447.959% |
| Cell Source, Inc. | - USD | -Infinity% |
| Regen BioPharma, Inc. | 176.56 Thousand USD | -459.572% |
| Regen BioPharma, Inc. | 176.56 Thousand USD | -459.572% |
| NovAccess Global Inc. | - USD | -Infinity% |
| Affymax, Inc. | 1.35 Million USD | 27.201% |
| Itoco Inc. | - USD | -Infinity% |
| Rasna Therapeutics, Inc. | - USD | -Infinity% |
| Pathfinder Cell Therapy, Inc. | - USD | -Infinity% |
| Mobile Lads Corp. | - USD | -Infinity% |
| CytoDyn Inc. | -29 Thousand USD | 3506.831% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| NDT Pharmaceuticals Inc. | - USD | -Infinity% |
| NanoSphere Health Sciences Inc. | - USD | -Infinity% |
| Alseres Pharmaceuticals, Inc. | 450.04 Thousand USD | -119.53% |
| SYBLEU INC | 11.69 Thousand USD | -8347.17% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| ImmunoCellular Therapeutics, Ltd. | - USD | -Infinity% |
| International Stem Cell Corporation | 4.6 Million USD | 78.559% |
| Bioxytran, Inc. | -8285.00 USD | 12024.937% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | - USD | -Infinity% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | - USD | -Infinity% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | - USD | -Infinity% |
| Adhera Therapeutics, Inc. | - USD | -Infinity% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | - USD | -Infinity% |
| Innovation Pharmaceuticals Inc. | -373 Thousand USD | 364.874% |
| Neutra Corp. | 14.33 Thousand USD | -6792.089% |
| Windtree Therapeutics, Inc. | -82 Thousand USD | 1304.855% |
| PureTech Health plc | -1.6 Million USD | 161.633% |
| Coeptis Therapeutics, Inc. | -1 Million USD | 198.676% |
| IXICO plc | 3.27 Million USD | 69.787% |
| IntelGenx Technologies Corp. | -694 Thousand USD | 242.36% |
| Gelesis Holdings, Inc. | -1.79 Million USD | 155.164% |
| CSL Limited | 7.7 Billion USD | 99.987% |
| Cellectis S.A. | 18 Thousand USD | -5388.783% |